CRANE NXT CO (CXT) Stock Fundamental Analysis

NYSE:CXT • US2244411052

52.76 USD
-0.74 (-1.38%)
At close: Feb 13, 2026
52.76 USD
0 (0%)
After Hours: 2/13/2026, 8:04:00 PM
Fundamental Rating

5

CXT gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 122 industry peers in the Electronic Equipment, Instruments & Components industry. CXT scores excellent on profitability, but there are concerns on its financial health. CXT scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year CXT was profitable.
  • CXT had a positive operating cash flow in the past year.
  • In the past 5 years CXT has always been profitable.
  • CXT had a positive operating cash flow in each of the past 5 years.
CXT Yearly Net Income VS EBIT VS OCF VS FCFCXT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • CXT has a Return On Assets of 5.30%. This is in the better half of the industry: CXT outperforms 72.13% of its industry peers.
  • CXT has a better Return On Equity (12.74%) than 80.33% of its industry peers.
  • CXT's Return On Invested Capital of 8.78% is fine compared to the rest of the industry. CXT outperforms 78.69% of its industry peers.
  • CXT had an Average Return On Invested Capital over the past 3 years of 11.44%. This is above the industry average of 8.95%.
Industry RankSector Rank
ROA 5.3%
ROE 12.74%
ROIC 8.78%
ROA(3y)7.07%
ROA(5y)6.96%
ROE(3y)16.14%
ROE(5y)16.86%
ROIC(3y)11.44%
ROIC(5y)10.83%
CXT Yearly ROA, ROE, ROICCXT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • With an excellent Profit Margin value of 9.80%, CXT belongs to the best of the industry, outperforming 82.79% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CXT has grown nicely.
  • CXT has a better Operating Margin (17.59%) than 92.62% of its industry peers.
  • In the last couple of years the Operating Margin of CXT has grown nicely.
  • CXT's Gross Margin of 43.20% is fine compared to the rest of the industry. CXT outperforms 75.41% of its industry peers.
  • In the last couple of years the Gross Margin of CXT has grown nicely.
Industry RankSector Rank
OM 17.59%
PM (TTM) 9.8%
GM 43.2%
OM growth 3Y-11.5%
OM growth 5Y9.05%
PM growth 3Y-16.95%
PM growth 5Y5.97%
GM growth 3Y-3.13%
GM growth 5Y3.98%
CXT Yearly Profit, Operating, Gross MarginsCXT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 10 20 30 40

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CXT is still creating some value.
  • Compared to 1 year ago, CXT has more shares outstanding
  • The number of shares outstanding for CXT has been reduced compared to 5 years ago.
  • Compared to 1 year ago, CXT has a worse debt to assets ratio.
CXT Yearly Shares OutstandingCXT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CXT Yearly Total Debt VS Total AssetsCXT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 2.15 indicates that CXT is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.15, CXT is doing worse than 60.66% of the companies in the same industry.
  • The Debt to FCF ratio of CXT is 6.27, which is on the high side as it means it would take CXT, 6.27 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of CXT (6.27) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.89 indicates that CXT is somewhat dependend on debt financing.
  • CXT has a worse Debt to Equity ratio (0.89) than 86.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 6.27
Altman-Z 2.15
ROIC/WACC0.94
WACC9.38%
CXT Yearly LT Debt VS Equity VS FCFCXT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.26 indicates that CXT should not have too much problems paying its short term obligations.
  • CXT has a Current ratio of 1.26. This is amonst the worse of the industry: CXT underperforms 80.33% of its industry peers.
  • CXT has a Quick Ratio of 1.26. This is a bad value and indicates that CXT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CXT has a worse Quick ratio (0.94) than 80.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.94
CXT Yearly Current Assets VS Current LiabilitesCXT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

4

3. Growth

3.1 Past

  • CXT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.92%.
  • Measured over the past 5 years, CXT shows a small growth in Earnings Per Share. The EPS has been growing by 1.12% on average per year.
  • Looking at the last year, CXT shows a quite strong growth in Revenue. The Revenue has grown by 11.43% in the last year.
  • Measured over the past years, CXT shows a decrease in Revenue. The Revenue has been decreasing by -9.71% on average per year.
EPS 1Y (TTM)-4.92%
EPS 3Y-19.21%
EPS 5Y1.12%
EPS Q2Q%5.83%
Revenue 1Y (TTM)11.43%
Revenue growth 3Y7.33%
Revenue growth 5Y-9.71%
Sales Q2Q%19.49%

3.2 Future

  • Based on estimates for the next years, CXT will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.53% on average per year.
  • CXT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.38% yearly.
EPS Next Y11.95%
EPS Next 2Y11.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.98%
Revenue Next 2Y5.38%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CXT Yearly Revenue VS EstimatesCXT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CXT Yearly EPS VS EstimatesCXT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

8

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 13.00, CXT is valued correctly.
  • Compared to the rest of the industry, the Price/Earnings ratio of CXT indicates a rather cheap valuation: CXT is cheaper than 90.16% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.19, CXT is valued rather cheaply.
  • The Price/Forward Earnings ratio is 11.61, which indicates a very decent valuation of CXT.
  • 91.80% of the companies in the same industry are more expensive than CXT, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of CXT to the average of the S&P500 Index (28.06), we can say CXT is valued rather cheaply.
Industry RankSector Rank
PE 13
Fwd PE 11.61
CXT Price Earnings VS Forward Price EarningsCXT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CXT indicates a rather cheap valuation: CXT is cheaper than 90.98% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, CXT is valued cheaply inside the industry as 85.25% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.55
EV/EBITDA 9.72
CXT Per share dataCXT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • CXT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CXT has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.09
PEG (5Y)11.6
EPS Next 2Y11.53%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

  • CXT has a Yearly Dividend Yield of 1.36%.
  • Compared to an average industry Dividend Yield of 0.47, CXT pays a better dividend. On top of this CXT pays more dividend than 91.80% of the companies listed in the same industry.
  • CXT's Dividend Yield is slightly below the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.36%

5.2 History

  • On average, the dividend of CXT grows each year by 6.42%, which is quite nice.
  • CXT has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)6.42%
Div Incr Years0
Div Non Decr Years0
CXT Yearly Dividends per shareCXT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • CXT pays out 24.82% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of CXT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP24.82%
EPS Next 2Y11.53%
EPS Next 3YN/A
CXT Yearly Income VS Free CF VS DividendCXT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
CXT Dividend Payout.CXT Dividend Payout, showing the Payout Ratio.CXT Dividend Payout.PayoutRetained Earnings

CRANE NXT CO

NYSE:CXT (2/13/2026, 8:04:00 PM)

After market: 52.76 0 (0%)

52.76

-0.74 (-1.38%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-11
Earnings (Next)05-05
Inst Owners114.42%
Inst Owner ChangeN/A
Ins Owners0.25%
Ins Owner Change3.38%
Market Cap3.03B
Revenue(TTM)1.66B
Net Income(TTM)154.70M
Analysts81.82
Price Target94.28 (78.7%)
Short Float %12.64%
Short Ratio9.41
Dividend
Industry RankSector Rank
Dividend Yield 1.36%
Yearly Dividend0.68
Dividend Growth(5Y)6.42%
DP24.82%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-27
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.72%
Min EPS beat(2)0.03%
Max EPS beat(2)1.41%
EPS beat(4)3
Avg EPS beat(4)1.08%
Min EPS beat(4)-1.06%
Max EPS beat(4)3.95%
EPS beat(8)6
Avg EPS beat(8)1.32%
EPS beat(12)10
Avg EPS beat(12)6.53%
EPS beat(16)13
Avg EPS beat(16)6.15%
Revenue beat(2)1
Avg Revenue beat(2)-0.28%
Min Revenue beat(2)-2.45%
Max Revenue beat(2)1.89%
Revenue beat(4)2
Avg Revenue beat(4)-0.1%
Min Revenue beat(4)-2.54%
Max Revenue beat(4)2.69%
Revenue beat(8)4
Avg Revenue beat(8)0.56%
Revenue beat(12)6
Avg Revenue beat(12)0.73%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.98%
EPS NY rev (1m)0.04%
EPS NY rev (3m)-1.49%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)0.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.54%
Valuation
Industry RankSector Rank
PE 13
Fwd PE 11.61
P/S 1.92
P/FCF 17.55
P/OCF 13.97
P/B 2.5
P/tB N/A
EV/EBITDA 9.72
EPS(TTM)4.06
EY7.7%
EPS(NY)4.55
Fwd EY8.62%
FCF(TTM)3.01
FCFY5.7%
OCF(TTM)3.78
OCFY7.16%
SpS27.5
BVpS21.14
TBVpS-9.06
PEG (NY)1.09
PEG (5Y)11.6
Graham Number43.95
Profitability
Industry RankSector Rank
ROA 5.3%
ROE 12.74%
ROCE 12.04%
ROIC 8.78%
ROICexc 9.45%
ROICexgc 35.12%
OM 17.59%
PM (TTM) 9.8%
GM 43.2%
FCFM 10.93%
ROA(3y)7.07%
ROA(5y)6.96%
ROE(3y)16.14%
ROE(5y)16.86%
ROIC(3y)11.44%
ROIC(5y)10.83%
ROICexc(3y)12.73%
ROICexc(5y)12.19%
ROICexgc(3y)46.7%
ROICexgc(5y)44.71%
ROCE(3y)14.96%
ROCE(5y)14.57%
ROICexgc growth 3Y-23.13%
ROICexgc growth 5Y12.65%
ROICexc growth 3Y-18.15%
ROICexc growth 5Y5.03%
OM growth 3Y-11.5%
OM growth 5Y9.05%
PM growth 3Y-16.95%
PM growth 5Y5.97%
GM growth 3Y-3.13%
GM growth 5Y3.98%
F-Score4
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 6.27
Debt/EBITDA 2.86
Cap/Depr 43.72%
Cap/Sales 2.8%
Interest Coverage 5.31
Cash Conversion 57.22%
Profit Quality 111.57%
Current Ratio 1.26
Quick Ratio 0.94
Altman-Z 2.15
F-Score4
WACC9.38%
ROIC/WACC0.94
Cap/Depr(3y)44.3%
Cap/Depr(5y)36.54%
Cap/Sales(3y)2.63%
Cap/Sales(5y)2.17%
Profit Quality(3y)119.51%
Profit Quality(5y)128.53%
High Growth Momentum
Growth
EPS 1Y (TTM)-4.92%
EPS 3Y-19.21%
EPS 5Y1.12%
EPS Q2Q%5.83%
EPS Next Y11.95%
EPS Next 2Y11.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.43%
Revenue growth 3Y7.33%
Revenue growth 5Y-9.71%
Sales Q2Q%19.49%
Revenue Next Year6.98%
Revenue Next 2Y5.38%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.68%
EBIT growth 3Y-5.02%
EBIT growth 5Y-1.54%
EBIT Next Year23.49%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y6.61%
FCF growth 3Y-11.36%
FCF growth 5Y-6.44%
OCF growth 1Y2.51%
OCF growth 3Y-7.59%
OCF growth 5Y-4.84%

CRANE NXT CO / CXT FAQ

What is the fundamental rating for CXT stock?

ChartMill assigns a fundamental rating of 5 / 10 to CXT.


Can you provide the valuation status for CRANE NXT CO?

ChartMill assigns a valuation rating of 8 / 10 to CRANE NXT CO (CXT). This can be considered as Undervalued.


What is the profitability of CXT stock?

CRANE NXT CO (CXT) has a profitability rating of 8 / 10.


How financially healthy is CRANE NXT CO?

The financial health rating of CRANE NXT CO (CXT) is 2 / 10.


Is the dividend of CRANE NXT CO sustainable?

The dividend rating of CRANE NXT CO (CXT) is 6 / 10 and the dividend payout ratio is 24.82%.